Physician profile
George L Adams
NPI 1962504100
$4,149,480.44
in general payments reported to CMS, 2019-2025
53 companies · $704K in 2025
The $704K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $305K · 2020: $175K · 2021: $799K · 2022: $590K · 2023: $655K · 2024: $921K · 2025: $704K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2.0M · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $166K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31K · Food and Beverage: $12K · Long Term Medical Supply Or Device Loan: $11K · Honoraria: $5,292 · Travel and Lodging: $4,727 · Acquisitions: $1,110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,048,957.39 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $165,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $30,760.00 |
| Food and Beverage | $12,406.55 |
| Long Term Medical Supply Or Device Loan | $11,000.00 |
| Honoraria | $5,291.67 |
| Travel and Lodging | $4,727.17 |
| Acquisitions | $1,109.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cordis US Corp. | $2,502,829.48 | 2021-2025 | Mynx Control, Mynx Control Venous, Selution Slr Pta |
| Boston Scientific Corporation | $651,080.40 | 2019-2025 | General - Therapies, Watchman Flx, Jetstream Sc |
| Shockwave Medical, INC | $441,855.96 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $132,011.17 | 2019-2025 | Supera, Diamondback Peripheral, Amplatzer Amulet |
| Cardiovascular Systems INC. | $118,690.93 | 2019-2023 | Diamondback Coronary |
| Cook Incorporated | $89,300.00 | 2019-2025 | Zilver Ptx |
| W. L. Gore & Associates, INC. | $55,509.38 | 2019-2024 | Product In Development, Gore Viabahn Vbx Balloon Expandable Endo, Viabahn Endoprosthesis With Propaten Bioactive Surface |
| Philips North America LLC | $45,490.89 | 2019-2024 | (P84) Igt Devices Systems |
| Bard Peripheral Vascular, INC. | $18,574.74 | 2020-2021 | |
| Asahi Intecc USA, INC. | $13,586.24 | 2019-2025 | Peripheral Vascular, Asahi Peripheral Vascular Wires, Asahi Coronary Wires |
| Angiodynamics, INC. | $13,496.25 | 2021-2025 | Auryon Laser System 100-120 Vac, Angiovac, Alphavac |
| Asahi Intecc Co., Ltd. | $12,043.24 | 2019 | |
| Heraeus Medical Components, LLC | $10,575.00 | 2020-2021 | |
| Intact Vascular, INC. | $9,004.37 | 2019 | |
| Surmodics, INC. | $8,101.60 | 2019-2025 | Pounce Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Venous Thrombectomy System |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Venturemed Group, INC. | $7,061.15 | 2019-2023 | Flex Vessel Prep System |
| Janssen Pharmaceuticals, INC | $6,805.94 | 2020-2023 | Xarelto |
| Cms Imaging, INC. | $3,920.04 | 2021-2025 | |
| Devoro Medical INC. | $2,606.66 | 2020-2021 | |
| Reflow Medical INC | $2,507.72 | 2025 | |
| Cook Medical LLC | $1,355.21 | 2019-2025 | Zilver Ptx, Micropuncture |
| Mercator Medsystems, INC. | $500.00 | 2020 | |
| Terumo Medical Corporation | $350.00 | 2019 | |
| Medtronic, INC. | $310.83 | 2022-2023 | Onyx Frontier, Hawkone |
| Abiomed | $287.97 | 2019-2022 | |
| Inspiremd Ltd | $272.00 | 2023-2024 | Cguard, Cguard |
| Avantec Vascular Corporation | $166.44 | 2021 | |
| Irhythm Technologies, INC. | $165.74 | 2024 | Zio Xt Patch, Zio Monitor |
| Novartis Pharmaceuticals Corporation | $125.00 | 2022 | |
| Merit Medical Systems INC | $104.35 | 2023 | |
| Sirtex Medical INC | $97.70 | 2023 | Lava Les (Liquid Embolic System) |
| Heartflow, INC. | $97.31 | 2021 | |
| Pfizer INC. | $96.29 | 2019-2025 | |
| Zoll Circulation INC | $88.65 | 2022 | |
| Baxter Healthcare | $67.62 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Mimedx Group, INC. | $46.30 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.84 | 2024-2025 | Jardiance |
| Stryker Corporation | $34.29 | 2025 | Artix Mt |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.82 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $24.57 | 2020 | |
| Bridgebio Pharma, INC. | $23.16 | 2025 | Attruby |
| Amgen INC. | $20.36 | 2025 | Repatha |
| Impulse Dynamics (USA) INC. | $19.88 | 2024 | Optimizer |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $16.88 | 2019 | |
| Chiesi USA, INC. | $16.72 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $16.37 | 2023 | Farxiga |
| Celgene Corporation | $16.22 | 2023 | Camzyos |
| Novo Nordisk INC | $16.21 | 2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $15.68 | 2025 | Shingrix, Arexvy |
| Contego Medical, INC | $10.87 | 2023 | Excipio Sv |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$143,950.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$8,168.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.